Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ketorolac tromethamine + lidocaine hydrochloride + isopropyl alcohol
- Development stage
- Unknown
- Lead developer
- Fosun Pharma USA
- Modality
- Small Molecules
- Administration
- Intramuscular, Infiltration, Nerve Block, Topical
01
Overview
A packaged combination pharmaceutical kit containing **ketorolac tromethamine**, **lidocaine hydrochloride**, and **isopropyl alcohol** as separate components rather than a single co-formulated product. The kit is associated with Fosun Pharma USA for pain-management procedures in which ketorolac provides short-term analgesia through inhibition of prostaglandin synthesis via cyclooxygenase blockade, lidocaine hydrochloride provides local anesthesia by reversible blockade of voltage-gated sodium channels, and isopropyl alcohol serves as a disinfecting component for vial or skin preparation. The product appears to be marketed under names including KETOROCAINE L KIT and ACUNISTAT variants, and is intended for procedural or acute pain settings rather than chronic therapy.
- Brand names
- KETOROCAINE L KITACUNISTAT-30ACUNISTAT30ACUNISTAT 30ACUNISTAT-60ACUNISTAT60ACUNISTAT 60
- Other names
- ketorolac tromethamine + lidocaine hydrochloride + isopropyl alcohol
02
Targets
NaV (Voltage-gated sodium channels)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on ketorolac tromethamine + lidocaine hydrochloride + isopropyl alcohol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ketorolac tromethamine + lidocaine hydrochloride + isopropyl alcohol.